These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38502355)

  • 1. Genome-wide analyses reveal the regulatory roles of DNA methylation-regulated alternative promoter transcripts in breast cancer.
    Song Y; Shen T; Sun H; Wang X
    Hum Genet; 2024 Mar; 143(3):385-399. PubMed ID: 38502355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer.
    Dutertre M; Gratadou L; Dardenne E; Germann S; Samaan S; Lidereau R; Driouch K; de la Grange P; Auboeuf D
    Cancer Res; 2010 May; 70(9):3760-70. PubMed ID: 20406972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype.
    Chen XQ; Zhang F; Su QC; Zeng C; Xiao FH; Peng Y
    Clin Epigenetics; 2020 Jan; 12(1):16. PubMed ID: 31959227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumor heterogeneity index of breast carcinomas based on DNA methylation profiles.
    Campoy EM; Branham MT; Mayorga LS; Roqué M
    BMC Cancer; 2019 Apr; 19(1):328. PubMed ID: 30953488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of epigenetically regulated genes in breast cancer cell lines.
    Loss LA; Sadanandam A; Durinck S; Nautiyal S; Flaucher D; Carlton VE; Moorhead M; Lu Y; Gray JW; Faham M; Spellman P; Parvin B
    BMC Bioinformatics; 2010 Jun; 11():305. PubMed ID: 20525369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.
    Rodenhiser DI; Andrews J; Kennette W; Sadikovic B; Mendlowitz A; Tuck AB; Chambers AF
    Breast Cancer Res; 2008; 10(4):R62. PubMed ID: 18638373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4 and H3 are associated with breast tumors.
    Paydar P; Asadikaram G; Nejad HZ; Akbari H; Abolhassani M; Moazed V; Nematollahi MH; Ebrahimi G; Fallah H
    J Cell Biochem; 2019 Aug; 120(8):13726-13736. PubMed ID: 30938887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer.
    Ramos EA; Grochoski M; Braun-Prado K; Seniski GG; Cavalli IJ; Ribeiro EM; Camargo AA; Costa FF; Klassen G
    PLoS One; 2011; 6(12):e29461. PubMed ID: 22220212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
    Vos S; Moelans CB; van Diest PJ
    Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.
    Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
    BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the nexus between the tumor immune microenvironment and DNA methylation in subgrouping estrogen receptor-positive breast cancer.
    Chen XQ; Zhang F; Xiao FH; Peng Y
    Breast Cancer; 2021 Nov; 28(6):1252-1260. PubMed ID: 33966175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
    Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
    Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage-specific methylome screen identifies that NEFL is downregulated by promoter hypermethylation in breast cancer.
    Kang S; Kim B; Park SB; Jeong G; Kang HS; Liu R; Kim SJ
    Int J Oncol; 2013 Nov; 43(5):1659-65. PubMed ID: 24026393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer.
    Wee EJ; Peters K; Nair SS; Hulf T; Stein S; Wagner S; Bailey P; Lee SY; Qu WJ; Brewster B; French JD; Dobrovic A; Francis GD; Clark SJ; Brown MA
    Oncogene; 2012 Sep; 31(38):4182-95. PubMed ID: 22231446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
    Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.
    Kulak MV; Cyr AR; Woodfield GW; Bogachek M; Spanheimer PM; Li T; Price DH; Domann FE; Weigel RJ
    Oncogene; 2013 Aug; 32(34):4043-51. PubMed ID: 22964634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide analysis of alternative transcripts in human breast cancer.
    Wen J; Toomer KH; Chen Z; Cai X
    Breast Cancer Res Treat; 2015 Jun; 151(2):295-307. PubMed ID: 25913416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer types.
    Mathios D; Hwang T; Xia Y; Phallen J; Rui Y; See AP; Maxwell R; Belcaid Z; Casaos J; Burger PC; McDonald KL; Gallia GL; Cope L; Kai M; Brem H; Pardoll DM; Ha P; Green JJ; Velculescu VE; Bettegowda C; Park CK; Lim M
    Int J Cancer; 2019 Dec; 145(12):3425-3435. PubMed ID: 31373686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide methylation analyses identifies Non-coding RNA genes dysregulated in breast tumours that metastasise to the brain.
    Pangeni RP; Olivaries I; Huen D; Buzatto VC; Dawson TP; Ashton KM; Davis C; Brodbelt AR; Jenkinson MD; Bièche I; Yang L; Latif F; Darling JL; Warr TJ; Morris MR
    Sci Rep; 2022 Jan; 12(1):1102. PubMed ID: 35058523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.